Cephalexin Powder, For Suspension
Product Images NDC 59651-322

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 59651-322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label- Principal Display Panel (125 mg per 5 mL)

This text provides information on Cephalexin for Oral Suspension, including dosage guidelines and instructions for reconstitution. The medication contains cephalexin monohydrate and should be stored properly. It is essential to mix the suspension before use and keep it refrigerated for up to 14 days. The product is distributed by Aurobindo Pharma USA, Inc. and is made in India.*

FDA Label Image

Package Label- Principal Display Panel (125 mg per 5 mL)

This text is a detailed description of Cephalexin for Oral Suspension, USP with a concentration of 250 mg per 5 ml when reconstituted. The usual pediatric dose is provided, along with instructions for preparation, storage, and usage. It contains cephalexin monohydrate equivalent to 5 g of cephalexin USP in a cherry-flavored mixture. The suspension needs to be stored in the refrigerator and can be kept for up to 14 days after reconstitution. The container must be shaken well before using and kept tightly closed. The medication is distributed by Aurobindo Pharma USA.*

FDA Label Image

Cephalexin-str.jpg (Cephalexin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.